Lactated Ringer's Superior to Normal Saline in Treating Sickle Cell Vaso-occlusive episodes: Study

This study aimed to compare, in adults admitted to the hospital for VOEs, the effectiveness of LR versus NS fluid resuscitation in patients with SCD. This was a multicenter cohort study. It was designed as a target trial emulation using data from the Premier PINC AI database over 2016-2022, which covers an approximate 25% sample of U.S. hospitalizations. This is a retrospective analysis of adults who were inpatients with sickle cell disease, had VOEs, and were treated with either LR or NS on hospital day 1. Patient encounters were entered between October 6, 2023 and June 20, 2024. There were 55,574 total patient encounters. Of those, 3,495 patients were treated with LR, and 52,079 patients received NS. The median age of the patients was 30 years, with an IQR of 25-37 years.

Patients with SCD who had VOEs were divided into two groups: LR (intervention) for fluid resuscitation on hospital day 1, and patients NS (control) for fluid resuscitation on day 1. A primary outcome was the number of HFDs at day 30. Secondary outcomes were also length of stay and 30-day readmission risk. TMLE was used to estimate marginal effect values. The paper also analyzed how treatment effects vary with the volume of fluids infused in patients.

Results

• Patients who received LR spent more hospital-free days than did those who received NS, with a marginal mean difference of 0.4 days (95% CI, 0.1-0.6 days).

• LR was associated with shorter hospital stay, with a marginal mean reduction of 0.4 days (95% CI, −0.7 to −0.1 days).

• The patients who were assigned to LR had fewer chances of readmission in 30 days with a marginal risk difference of 5.8% (95% CI, −9.8% to −1.8%).

• On patients who received more than or equal to 2 liters of fluid, LR was significantly better as compared with NS. On patients who received less than 2L, there was no difference regarding risk compared with the two fluids.

It is suggested that lactated Ringer solution should be used for fluid resuscitation instead of normal saline in a patient with SCD at the time of experiencing a vaso-occlusive episode. Hospital free days, hospital days, and the probability of readmission were significantly better in patients who received LR. These findings show the use of LR to be more effective in improving clinical outcomes and thus be included in the therapy regimens.

Reference:

Alwang, A. K., Law, A. C., Klings, E. S., Cohen, R. T., & Bosch, N. A. (2024). Lactated Ringer vs normal saline solution during sickle cell Vaso-occlusive episodes. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2024.4428